Todd Golub
Affiliations: | Pediatric Oncology | Dana Farber Cancer Institute, Harvard Medical School |
Google:
"Todd Golub"Children
Sign in to add trainee| Uri Ben-David | post-doc | Broad Institute (MIT/Harvard) (Neurotree) | |
| Stephen L. Lessnick | post-doc | 1999-2003 | Dana Farber Cancer Institute, Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Krill-Burger JM, Dempster JM, Borah AA, et al. (2023) Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. Genome Biology. 24: 192 |
| Hoge ACH, Getz M, Zimmer A, et al. (2022) Publisher Correction: DNA-based copy number analysis confirms genomic evolution of PDX models. Npj Precision Oncology. 6: 50 |
| Hoge ACH, Getz M, Zimmer A, et al. (2022) DNA-based copy number analysis confirms genomic evolution of PDX models. Npj Precision Oncology. 6: 30 |
| Bondeson DP, Paolella BR, Asfaw A, et al. (2022) Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer. Nature Cancer |
| Pagès M, Rotem D, Gydush G, et al. (2022) Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine. Neuro-Oncology |
| Malone CF, Dharia NV, Kugener G, et al. (2021) Selective modulation of a pan-essential protein as a therapeutic strategy in cancer. Cancer Discovery |
| Dharia NV, Kugener G, Guenther LM, et al. (2021) A first-generation pediatric cancer dependency map. Nature Genetics |
| Prensner JR, Enache OM, Luria V, et al. (2021) Noncanonical open reading frames encode functional proteins essential for cancer cell survival. Nature Biotechnology |
| Cohen-Sharir Y, McFarland JM, Abdusamad M, et al. (2021) Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature |
| Corsello SM, Nagari RT, Spangler RD, et al. (2020) Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nature Cancer. 1: 235-248 |